Authors: SENDEROWICZ AM HEADLEE D LUSH R ARBUCK S BAUER K FIGG WD MURGO A INOUE K KOBASHI S KUWABARA T SAUSVILLE EA

Citation: Am. Senderowicz et al., PHASE-I TRIAL OF INFUSIONAL UCN-01, A NOVEL PROTEIN-KINASE INHIBITOR,IN PATIENTS WITH REFRACTORY NEOPLASMS, Annals of oncology, 9, 1998, pp. 426-426

Authors: WELLES L SAVILLE MW LIETZAU J PLUDA JM WYVILL KM FEUERSTEIN I FIGG WD LUSH R ODOM J WILSON WH FAJARDO MT HUMPHREY RW FEIGAL E TUCK D STEINBERG SM BRODER S YARCHOAN R

Citation: L. Welles et al., PHASE-II TRIAL WITH DOSE TITRATION OF PACLITAXEL FOR THE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA, Journal of clinical oncology, 16(3), 1998, pp. 1112-1121

Authors: FIGG WD CHRISTIAN MC LUSH R LINK CJ DAVIS P KOHN E SAROSY G ROTHENBERG ML WEISS RB RYAN N JACOBS J REED E

Citation: Wd. Figg et al., PHARMACOKINETICS OF ELEMENTAL PLATINUM (ULTRAFILTRATE AND TOTAL) AFTER A 30 MINUTE INTRAVENOUS-INFUSION OF ORMAPLATIN, Biopharmaceutics & drug disposition, 18(4), 1997, pp. 347-359

Authors: KROBOTH P FOLAN M LUSH R CHAIKIN PC BARBHAIYA RH SALAZAR DE

Citation: P. Kroboth et al., COADMINISTRATION OF NEFAZODONE AND BENZODIAZEPINES .2. PHARMACODYNAMIC ASSESSMENT, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 142-142